Status:

TERMINATED

Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure

Lead Sponsor:

Solvay Pharmaceuticals

Conditions:

Acute Decompensated Heart Failure; Renal Dysfunction

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine the efficacy and safety of IV SLV320 in acute heart failure patients with renal dysfunction.

Detailed Description

The purpose of this study is to determine the efficacy and safety of IV SLV320 in acute heart failure patients with renal dysfunction.

Eligibility Criteria

Inclusion

  • Inclusion Criteria Renal dysfunction defined as estimated eGFR of 20-80 mL/min; history of systolic or diastolic chronic heart failure of at least 14 days duration for which loop diuretic therapy has been prescribed; clinical evidence for volume overload; BNP ≥ 500 pg/mL or NT-pro-BNP \> 2000 pg/mL; hospitalization.
  • Exclusion Criteria Have low output syndrome, defined as having the need for treatment with I.V. inotropes or vasopressors; Need mechanical ventilation; Have significant stenotic valvular disease (severe aortic or mitral stenosis); Have myocardial infarction or hemodynamically destabilizing significant arrythmias (ventricular tachycardia, bradyarrythmias with slow ventricular rate \[\<45 bpm\] or atrial fibrillation/flutter with a rapid ventricular response of \>120 bpm), or electrocardiographic evidence of 2nd degree heart block (Mobitz Type II) or 3rd degree AV-block in the absence of a pacemaker, within 30 days of screening; Have acute myocarditis or hypertrophic obstructive, restrictive, or constrictive cardiomyopathy

Exclusion

    Key Trial Info

    Start Date :

    February 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2010

    Estimated Enrollment :

    46 Patients enrolled

    Trial Details

    Trial ID

    NCT00744341

    Start Date

    February 1 2009

    End Date

    January 1 2010

    Last Update

    September 17 2010

    Active Locations (105)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 27 (105 locations)

    1

    S320.2.011 Site # 548

    Alameda, California, United States

    2

    S320.2.011 Site # 566

    Banning, California, United States

    3

    S320.2.011 Site # 551

    Inglewood, California, United States

    4

    S320.2.011 Site # 564

    Bridgeport, Connecticut, United States